SUMO1P3 and neoplasm: ROC curve analysis showed that SUMO1P3 is a promising biomarker for predicting aggressive tumor phenotypes, with an area under the curve (AUC) of 0.848 (low- vs high-grade NMIBC) and 0.878 (low-grade NMIBC vs MIBC) (Figure 3A).